Body Contouring

GLP-1 Weight-Loss Medications: A Plastic Surgeon's Science-Based Guide

Body ContouringOp. Dr. Yasemin Aydınlı·12 min read

In recent years, a steadily growing group of patients has come to my clinic: people who lost a great deal of weight with GLP-1 weight-loss medications — popularly called the 'weight-loss injection' — but are unhappy with the body they ended up with. That is why I prepared this article. Here I want to explain these medications not first as a plastic surgeon, but by conveying what science says exactly as it is: how they work, who they are not suitable for, which doctor a person who wants them should see, by what mechanism their risks arise, and finally my own area of expertise — the sagging that appears after weight loss and surgical planning.

Let me clarify two things from the outset. One: these medications are not bad. In the right patient, under the right supervision, they are among the most effective tools of recent years in treating obesity. Two: these medications are not candy. Used unconsciously, without supervision and obtained over the internet, they carry real risks. My aim is neither to encourage nor to frighten — only to equip you with correct information.

An important note: I am not the physician who prescribes these medications; I am a plastic surgeon. The information here is for general education; decisions about starting, dosing and stopping are the job of the endocrinology or internal-medicine doctor following you.

🎥 The video version of this article

What are GLP-1 medications (the weight-loss injection) and how do they work?

These medications mimic gut hormones called 'incretins'. When you eat, your intestines release a hormone called GLP-1. The weight-loss effect comes precisely from three actions of this hormone.

The active substances differ: semaglutide and liraglutide work only through GLP-1; tirzepatide is dual-acting — in addition to GLP-1 it also activates a second incretin hormone called GIP, and in studies this dual action provides stronger weight loss. In short, these are not 'fat-burning' drugs; they are drugs that push you to eat less and stay full longer. Weight loss is the result of reduced calorie intake.

Who should not use them? (Absolute contraindications)

This is the most skipped and most important section. The situations below are not 'be careful' but 'do not use'.

There is also a 'not strictly forbidden, but this drug is not for you' group: people without a weight problem, at a normal weight, who just want to lose a few kilos. For someone with a body-mass index in the normal range to use these drugs for cosmetic purposes is both off-label and needlessly accepting risks such as muscle loss. These are a medical treatment, not an appearance accessory.

So who can use them? (Indication)

The scientific criterion is clear. These medications are approved for weight management in the following people:

If you do not know your BMI, the calculation is simple: divide your weight by the square of your height in meters. But I mention this not so you make the calculation alone and decide to take the drug, but so you can evaluate it with a doctor.

Which doctor should an interested person see, and how?

If only one thing from this article stays with you, let it be this section.

The right address: an endocrinologist or an internal-medicine specialist experienced in this area. Centers with an obesity clinic are ideal. Who you should not get it from: the internet, social media, an 'acquaintance', a beauty center, or anyone who has never examined you. This drug is a treatment that requires examination, tests and follow-up.

Before starting, your doctor should assess: your personal and family history of thyroid cancer, your history of pancreatitis, the state of your gallbladder, the possibility of pregnancy, the other medications you take, and whether you actually have an indication.

Why is the dose increased slowly?

This is a very important safety point. The drug is started at the lowest dose and increased gradually, at set intervals. Reaching the target dose can take a few months.

Why so slowly? Because this drug, which slows the stomach, can cause severe nausea, vomiting and stomach-paralysis-like states when the dose is raised quickly. The literature reports serious gastroparesis (a halt in stomach movements) in patients who skipped the schedule and raised the dose fast. Increasing the dose on your own to 'lose weight faster' is one of the most dangerous mistakes. The titration schedule is not bureaucracy but a safety mechanism. Also, not everyone needs to reach the highest dose; for a patient who cannot tolerate the target dose, staying at a lower maintenance dose is also an option.

Risks and side effects — with their mechanisms

Let me explain the risks together with why they happen. My aim is not to frighten but to inform; because you can only manage a risk you know about. Most of these are manageable.

Digestive system (most common): nausea, vomiting, diarrhea, constipation. The reason is that the drug slows the stomach and changes digestion. It is usually mild and decreases as you get used to the drug; one aim of the slow dose increase is to minimize these.

Gastroparesis (stomach paralysis): excessive slowing of stomach emptying; it can lead to severe, persistent nausea and vomiting. The risk rises especially with rapid dose increases.

Gallbladder problems: rapid weight loss itself increases gallstone formation. The mechanism is this: most of the body's cholesterol is stored in fat tissue; during rapid weight loss this cholesterol is released and empties into the bile, the bile becomes oversaturated with cholesterol and crystallizes into stones. On top of this, the drug slows the contraction of the gallbladder — when the gallbladder does not empty fully, the bile stagnates and stone formation becomes even easier. So two mechanisms stack on top of each other.

Acute pancreatitis: rare but serious. There is an important distinction here; pancreatitis can occur through two separate paths. The first path (gallstone-related, probably the most common): if a gallstone that has formed dislodges and blocks the opening where the bile duct meets the pancreatic duct, the pancreas cannot discharge its enzyme and begins to digest itself. The second path (direct-effect hypothesis): GLP-1 receptors are also found in the pancreatic duct cells; it has been proposed that this stimulation could directly cause pancreatitis. To be honest, this direct effect is not definitively proven — large studies showed no significant increase in pancreatic events compared with placebo. We have a signal (case reports) but no firm causality. In any case, severe abdominal pain radiating to the back requires urgent evaluation; this is why the drug is not recommended in people with a history of pancreatitis.

Kidney: fluid loss from severe vomiting and diarrhea can cause acute kidney injury — that is, a side effect of a side effect. Plenty of fluids and monitoring symptoms are important.

Eye (a much-misreported topic): there are two separate things. The first is worsening of diabetic retinopathy; this is seen mainly in patients who already have diabetes and eye involvement, and the likely cause is not direct harm to the eye but the rapid drop in blood sugar (it also happens with intensive insulin therapy). So in someone without diabetes who is only losing weight, this is not an expected picture. The second is an optic-nerve problem called NAION; this is a newer and genuinely controversial signal — some studies found an increased risk, others did not, the absolute risk is very low and causality is unproven. The correct approach: if there is any change in your vision, see an eye doctor.

Anesthesia risk (directly relevant to my field): because the stomach is slowed, food can remain in the stomach even if the normal preoperative fasting time is observed. Under general anesthesia this means the risk of stomach contents passing into the lungs, that is, aspiration. I will return to this topic shortly.

Muscle loss and the 'weight-loss face'

When your body loses weight, it does not lose only fat; you also lose some muscle. This is the case with every weight loss. But there is an important finding with these drugs: in the large study that led to semaglutide's approval, about 40% of the weight lost was seen to be lean mass — that is, mainly muscle. With ordinary calorie restriction this proportion is about 25%. So the rate of muscle loss can be higher.

To be honest, the subject is still debated in the literature: in some newer studies the loss is mainly from fat, and muscle function — even grip strength — is preserved. So it would be wrong to say 'it will definitely melt your muscles'. But the risk is real and preventable.

Let me touch briefly on the look we call the 'weight-loss face' (I will cover this in detail in a separate article). It is not a mysterious side effect: with rapid weight loss the fat pads in the face — the tissues that give the cheeks youth and fullness — melt away quickly, and the skin cannot keep up with this volume loss. The result is sunken cheeks, sagging and an older-than-actual appearance. The same equation applies to the body: deflation of the breasts, excess skin on the abdomen and arms. Volume left fast, the envelope could not recover.

Evidence-based ways to preserve muscle and appearance

You cannot completely prevent muscle loss and excessive sagging, but you can significantly reduce them. Three things the literature points to:

  1. Enough protein. The foundation of preserving muscle mass. It is hard when your appetite is suppressed, so you have to prioritize it consciously; it is best to plan it with the support of a dietitian.
  2. Resistance exercise. The intervention with the strongest evidence. Weight or resistance training a few days a week preserves lean tissue. Walking is good, but on its own it is not enough to preserve muscle.
  3. Controlling the pace of loss. Excessively fast weight loss strains both muscle and skin. Set a reasonable, gradual goal with the doctor managing your medication.

These three both protect your health and improve your result if you later consider surgery.

Are these risks also seen with obesity surgery?

A frequently asked question. Understanding the distinction means understanding the source of the risk: some risks are tied to rapid and large weight loss itself — they appear whichever method you lose weight by. Others are specific to the drug and are not seen with surgery.

Common to both methods: gallstones (the rate in the first year after obesity surgery is quite high; the mechanism is exactly the same, which is why a protective drug is often given in surgery), gallstone-related pancreatitis, muscle loss and sagging. In fact, 'post-weight-loss body contouring' is a whole surgical field, and a significant portion of my patients are people who have had obesity surgery. So sagging is not specific to the injection; it depends on the pace and the amount.

Specific to the drug and not seen with surgery: stomach paralysis (gastroparesis), the direct-pancreatic-effect hypothesis, the thyroid C-cell signal, effects on the eye, and injection-related digestive side effects.

Post-weight-loss surgery: timing and anesthesia safety

Now my main field. You have lost weight, sagging has developed, and you want to correct it. There are two critical rules.

First rule — timing: do not have surgery before your weight has stabilized. After reaching your target weight, I ask that the weight remain stable for at least three to six months. Because the result of an abdominoplasty or body-contouring operation done while you are still losing weight is spoiled by the weight lost afterward. The order: first target weight, then stabilization, and surgery last.

Second rule — anesthesia safety (vital): if you use these medications, be sure to tell your surgeon and anesthesiologist before surgery. Because the drug slows the stomach, contents can remain in your stomach even if you have fasted; under general anesthesia this means a risk of aspiration. Current international guidelines recommend a patient-by-patient decision rather than a single template: the type of drug, the dose, how long it has been used and your side effects are all assessed. In practice there are different protocols — pausing weekly injections some time before surgery, applying a liquid diet before the operation, or the anesthesia team assessing the stomach with ultrasound. Your surgeon and anesthesiologist decide together which is right for you.

Your responsibility is single and simple: tell them everything you use — the injection, the pill, the supplement. The anesthesia team can only manage a risk it knows about.

Returning to the drug after surgery: during recovery the body needs protein and energy; wound healing is a serious metabolic task. Going through this period on a drug that suppresses appetite can adversely affect healing. When to return should be coordinated between your surgeon and the doctor who prescribes the drug.

Summary

Frequently Asked Questions

Does the weight-loss injection burn fat?

No. These drugs do not burn fat; by reducing appetite and slowing the stomach, they make you eat less and stay full longer. Weight loss is the result of reduced calorie intake.

Who should not use the weight-loss injection?

People with a personal or family history of medullary thyroid cancer or MEN 2 syndrome, pregnant women and those planning a pregnancy, people with a history of pancreatitis, and those allergic to the drug should not use it. It is also not suitable for people at a normal weight who just want to lose a few kilos. The decision is made by the doctor following you.

Can I have surgery while using the drug?

You can, but you must tell your surgeon and anesthesiologist that you use it. Because the drug slows the stomach, contents can remain even if you have fasted; under general anesthesia this means a risk of aspiration. Your team decides what preparation is needed before surgery.

When should I have surgery after losing weight?

Surgery is not recommended before your weight has stabilized. After reaching the target weight, the weight is expected to remain stable for at least three to six months; because the result of a body-contouring operation done while you are still losing weight can later be spoiled.

How do I reduce muscle loss and sagging?

Three things help most: getting enough protein, doing resistance (weight) exercise a few days a week, and keeping the pace of weight loss under control with your doctor. These both protect health and improve the result if surgery is later needed.

Are these risks also seen with obesity surgery?

Some of them, yes: gallstones, the pancreatitis linked to them, muscle loss and sagging are seen with both methods, because what causes them is rapid weight loss itself. Stomach paralysis, the effects the drug produces via receptors, and injection-related side effects, on the other hand, are specific to the drug.

About the Author

Op. Dr. Yasemin Aydınlı is a graduate of Hacettepe University English Medical Faculty and completed her specialty training at Ankara University. She is a member of TPRECD and ISAPS and works in aesthetic and reconstructive surgery in Istanbul.

This content is for general information only and does not replace medical advice. I am not the physician who prescribes these medications; make decisions about starting, dosing and stopping with the doctor following you. Every person is different; suitability and the process can only be determined by a personal examination and consultation.

Related Services

Tummy Tuck Liposuction
Op. Dr. Yasemin Aydınlı

Op. Dr. Yasemin Aydınlı

Plastic, Reconstructive and Aesthetic Surgeon

Offers personalized aesthetic solutions with a priority on naturalness and balance.

Let's assess your post-weight-loss body together

If you have lost a significant amount of weight and sagging bothers you, we can discuss a plan that suits you together — online or in person.

Get in Touch